Issue 12 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

32

No.

12

December 25, 2009Dec 25, 2009

Free

DOWNLOAD THE PDF

ASCO Annual Report Names Significant Clinical Research Advances Of Past Year

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

Bisphosphonates May Reduce Recurrent Breast Cancer

Study Finds High-Risk Women Reluctant To Take Tamoxifen

Cervical Cancer Screening Can Be Done Later, Less Often

No Benefit For Cetuximab In Early-Stage Colon Cancer

NCI Cooperative Group Clinical Trials Approved

Recent Issues

Volume 51 | Issue 06 - February 14, 2025

Volume 51 | Issue 05 - February 07, 2025

Volume 51 | Issue 04 - January 31, 2025

Volume 51 | Issue 03 - January 24, 2025

Volume 51 | Issue 02 - January 17, 2025

Volume 51 | Issue 01 - January 10, 2025